The 1st Israeli-UK Medicinal Chemistry Conference
The Israeli Section of Medicinal Chemistry of the Israel Chemical Society (ISM-ICS) together with the Medicinal Chemistry section of the Royal Society of Chemistry are organizing a 2-day bi-national conference on Medicinal Chemistry.
The conference details are:
The 1st Israeli-UK Medicinal Chemistry Conference
22-23 of April, 2012,
Weizmann Institute of Science, Rehovot, Israel
www.iamc.chemistry.org.il
RSC BMCS Malcolm Campbell Memorial Award 2011
The Biological and Medicinal Chemistry Sector of the RSC is proud to announce the winner of the Malcolm Campbell Memorial Award for 2011.
This year's winners are the Liverpool team of:
- Paul M O’Neill
- B Kevin Park
- Stephen A Ward
for work in the area of antimalarial drug discovery and chemical biology of Plasmodium falciparum.
The Malcolm Campbell Memorial Award commemorates Professor Campbell’s outstanding contributions in a broad range of chemistry and their applications to the understanding of bioactivity.
The award is awarded biennially and the 2011 prize was formally presented to the winning team during the RSC/SCI Medicinal Chemistry Symposium in Cambridge, 11-14 September 2011 – see http://www.rsc.org/Membership/Networking/InterestGroups/BMCS/Activities/CampbellAward.asp
The BMCS Committee wishes to express its gratitude for the high quality entries from both academia and industry for the 2011 award.
16th RSC-SCI Cambridge Medicinal Chemistry Symposium
The 16th biennial SCI/RSC Medicinal Chemistry Symposium recently took place at Churchill College Cambridge, between the 11th and 14th of September. In the region of 300 delegates from more than 25 countries were treated to three days of the latest developments and thinking in medicinal chemistry. The theme of this year’s meeting was “The Path forward: Collaboration or Competition?”, and, in keeping with that theme, many of the lectures highlighted the fruits of ongoing collaborative ventures. There were clear examples of cutting edge academic researchers reaching out to Big Pharma for help with development and commercialization of their ideas, and of Big Pharma making tools available for the furtherance of academic research, and reaching out to academics and biotechs seeking early stage partnerships around novel chemistries and chemical diversity. The more than 25 lectures covered topics in enzyme targets, ion channel/receptor targets and late breaking topics, in addition to lectures focussed on the specific meeting them. Many of the lectures presented important first disclosures of clinical development candidates, or revealed significant new clinical data. In addition to the lectures, there were more than fifty posters on an even wider diversity of topics, many of them prepared and presented by younger representatives of their respective organisations. Finally the delegates were challenged by the well known Chemistry World column writer and blog author Derek Lowe, to think about “What Next” for the industry. For the organising committee that means planning for the 17th meeting, which has already begun!
2nd RSC symposium on Chemical Biology for Drug Discovery
Tuesday-Wednesday, 20th-21st March 2012
AstraZeneca, Alderley Park, Macclesfield, UK
This symposium covers progress in the interdisciplinary field of Chemical Biology in enhancing our understanding of the molecular mechanisms of human biology in health and disease. Topics will include discovery and use of chemical probes, chemical modification of biological molecules, in-cell protein labelling, carbohydrate therapeutics and biomarkers, and the study of protein-protein interactions. This meeting is aimed at chemists and biologists from across the academic and industrial sectors interested in harnessing chemical science to answer fundamental questions in biology. The call for posters is now open, see http://www.maggichurchouseevents.co.uk/BMCS/index.htm Closing date for submissions is 21st February 2012.
The First Computationally Driven Drug Discovery (CDDD) Meeting has held in L’Aquila
On November 21-23, the auditorium of the Dompé Research Center in L’Aquila has hosted the first meeting on Computationally Driven Drug Discovery. The meeting has gathered together Italian computational chemists working in the broad field of drug discovery coming from both academia and industry. More than 160 scientists have attended and animated a very tight scientific program including more than 48 oral presentations, one poster session and two round tables. The event has allowed to bring together a very large, heterogenous but scientifically higly focused community, and has resulted in the definition of the state-of-the-art of the discipline in Italy.
For more information see www.cddd.it
